News

CBD Life Sciences Inc. (CBDL) Ignites Expanding Revenue Stream With RangeMe, Poised for Explosive Growth

RangeMe connects CBDL to over 200,000 retail buyers, including some of the world's largest retailers, driving exponential market opportunitiesSCOTTSDALE, AZ…

1 year ago

Join Nutriband’s Exclusive Live Investor Webinar and Q&A Session on October 17

ORLANDO, FL / ACCESSWIRE / October 2, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical solutions, is pleased…

1 year ago

Abbas Hussain Joins Moderna’s Board of Directors

Hussain brings more than 35 years of commercial leadership and operating experience in healthcare, most recently serving as CEO of…

1 year ago

Reviva to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

CUPERTINO, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage…

1 year ago

Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments

ATLANTA, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet…

1 year ago

OneMedNet Announces Board Member Transition to Drive Growth Post-IPO

MINNEAPOLIS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade…

1 year ago

Annovis Bio Inc. (NYSE: ANVS) Research Points to Potential Future Breakthroughs in AD Space Through Innovative Combinations

NEW YORK, Oct. 02, 2024 (GLOBE NEWSWIRE) -- via InvestorWire — Annovis Bio Inc. (NYSE: ANVS) today announces its placement…

1 year ago

Serina Therapeutics to Present at the 14th Annual Injectables Summit

HUNTSVILLE, AL, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its…

1 year ago

Better Choice Company to Provide Update on SRx Health Transaction at the 2024 Sidoti Virtual Conference on November 13th & 14th

SRx Health Revenue for the fiscal year ending September 30, 2024 is expected to increase over 20% year-over-year to over…

1 year ago